TNG Pharmaceuticals, Inc. Closes $4.6 Million Series A Financing

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOUISVILLE, Ky.--(BUSINESS WIRE)--TNG Pharmaceuticals, Inc. (TNG), an animal pharmaceutical company developing an innovative vaccine for cattle to aid in control of the horn fly, announced that it completed a $4.6 million Series A Preferred Stock financing on December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news